These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33587972)

  • 1. Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.
    Fan WJ; Teng F; Liu G; Zhao DW; Li JF; Luo YR; Zhang XX; Ma L; Guan J
    Radiother Oncol; 2021 Apr; 157():247-254. PubMed ID: 33587972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.
    Zhao DW; Fan WJ; Fang XM; Luo YR; Wei J; Chen NX; Zhang XX; Liu G; Li JF; Zang X; Li M; Meng L; Ma L
    Radiother Oncol; 2022 Jul; 172():91-98. PubMed ID: 35584742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
    Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
    Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients.
    Zhao D; Fan W; Jiang H; Meng L; Cai B; Zhang X; Yu W; Zhao L; Ma L
    Strahlenther Onkol; 2024 May; 200(5):377-388. PubMed ID: 37955647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients.
    Zhao DW; Teng F; Meng LL; Fan WJ; Luo YR; Jiang HY; Chen NX; Zhang XX; Yu W; Cai BN; Zhao LJ; Wang PG; Ma L
    Radiother Oncol; 2023 Jul; 184():109683. PubMed ID: 37120102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
    Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
    Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
    BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy.
    Zhao DW; Fang XM; Zhou SH; Luo YR; Wei J; Liu K; Meng LL; Liu G; Li JF; Zang X; Li M; Qiang XF; Jiang HY; Fan WJ; Zhang XX; Ma L
    Front Oncol; 2022; 12():870315. PubMed ID: 35664750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
    Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
    Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.
    Lee TF; Liou MH; Ting HM; Chang L; Lee HY; Wan Leung S; Huang CJ; Chao PJ
    Sci Rep; 2015 Aug; 5():13165. PubMed ID: 26289304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
    Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
    PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia.
    Zhang Y; Ou D; Gu Y; He X; Peng W
    Korean J Radiol; 2018; 19(4):758-766. PubMed ID: 29962882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia.
    Zhang Q; Wei YM; Qi YG; Li BS
    Korean J Radiol; 2018; 19(2):328-333. PubMed ID: 29520191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.
    Zeng L; Zhang Q; Ao F; Jiang CL; Xiao Y; Xie HH; Tang YQ; Gong XC; Li JG
    Auris Nasus Larynx; 2019 Jun; 46(3):457-464. PubMed ID: 30528104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
    Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
    BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic observation on the short-term change of xerostomia after intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma].
    Li Y; Zhao C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 50(1):33-7. PubMed ID: 25764925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on DWMRI in evaluating the influence of intensity modulated radiotherapy on salivary gland function of nasopharyngeal carcinoma patients].
    Li Y; Zhao C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 50(9):754-9. PubMed ID: 26696349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submandibular gland sparing in intensity-modulated radiotherapy for N0-stage nasopharyngeal carcinoma.
    Huang L; Zhang W; Zhuang T; Wu F; Li D; Zheng M; Lin B; Zhuang M; Chen Z
    Br J Radiol; 2014 Apr; 87(1036):20130651. PubMed ID: 24620926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of salivary function change in nasopharyngeal carcinoma treated by parotid-sparing radiotherapy.
    Liu WS; Kuo HC; Lin JC; Su MC; Lee JK; Chou MJ; Chou MC; Lee H
    Cancer J; 2006; 12(6):494-500. PubMed ID: 17207319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.